Stepwise algorithm combining HPV high-risk DNA-based assays and RNA-based assay for high grade CIN in women with abnormal smears reffered to colposcopy

Cancer Biomarkers

Volumn 7, Issue 3, 2010, Pages 133-139

  Halfon, Philippe ^a,c   Benmoura, Dominique ^a,b   Agostini, Aubert ^b   Khiri, Hacène ^c   Pénaranda, Guillaume ^c,d   Martineau, Agnès ^a   Blanc, Bernard ^a  

^a Hospital Ambroise Pare   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c Laboratoire Alphabio   (France)

^d CDL Pharma   (France)

Author keywords

colposcopy; DNA based assays; RNA based assays; stepwise algorithm

Indexed keywords

DNA; RNA;

ADULT; ADVANCED CANCER; ARTICLE; ASSAY; CANCER DIAGNOSIS; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; FRANCE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HYBRID CAPTURE II; INTERMETHOD COMPARISON; LINEAR ARRAY; MAJOR CLINICAL STUDY; NUCLISENS EASYQ HPV; PAPANICOLAOU TEST; PAPILLOCHECK; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PRIORITY JOURNAL; REALTIME HR HPV; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; DNA, VIRAL; FEMALE; FRANCE; GENETIC TECHNIQUES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REFERRAL AND CONSULTATION; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 79954559057     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2010-0156     Document Type: Article

References (21)

1. J.M. Walboomers, W.V. Jacobs, M.M. Manos et al., Human papillomavirus is anecessary cause of invasive cervical cancer worldwide, JPathol 189 (1999), 12-19. (Pubitemid 29406813)
2. G. Clifford, S. Franceschi, M. Diaz, N. Munoz and L.L. Villa, Chapter 3: HPV type-distribution in women with and with-out cervical neoplastic diseases, Vaccine 24(Suppl 3) (2006), S3/26-S3/34.
3. N.W. Bulkmans, J. Berkhof, L. Rozendaal et al., Human pa-pillomavirus DNA testing for the detection of cervical in-traepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial, Lancet 370 (2007), 1764-1772. (Pubitemid 350137476)
4. N.W. Bulkmans, L. Rozendaal, P.J. Snijders et al., POBAS-CAM, a population-based randomized controlled trial for im-plementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women, Int J Cancer 110 (2004), 94-101. (Pubitemid 38507208)
5. P. Halfon, D. Benmoura, A. Agostini et al., Relevance ofHPV mRNA detection in a population of ASCUS plus women using the Nucli SENS Easy Q((R)) HPV assay, J Clin Virol (2009)
6. P. halfon, D. Benmoura, H. Khiri et al., Comparison of the clinical performance of carcinogenic HPVtyping ofthe Linear Array and Papillochech HPV-screening assay, J Clin Virol (2009), Epub ahead of print.
7. CJ. Meijer, J. Berkhof, P.E. Castle et al., Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older, Int J Cancer 124 (2009), 516-520.
8. J. Cuzick, M. Arbyn, R. Sankaranarayanan et al., Overview of human papillomavirus-based and other novel options for cer-vical cancer screening in developed and developing countries, Vaccine 26(Suppl 10) (2008), K29-K41.
9. A. Szarewski, L. Ambroisine, L. Cadman et al., Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears, Cancer Epidemiol Biomarkers Prev 17 (2008), 3033-3042.
10. N. Wentzensen, M. Schiffman, S.T. Dunn et al., Grading the severity of cervical neoplasia based on combined histopathol-ogy, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma, Int J Cancer 124 (2009), 964-969.
11. G. Terry, L. Ho, P. Londesborough, J. Cuzick, I. Mielzynska-Lohnas and A. Lorincz, Detection of high-risk HPV types by the hybrid capture 2 test, J Med Virol 65 (2001), 155-162.
12. S. Huang, N. Tang, W. Mak, B. Erickson, J. Salituro and Y. Li, Principles and analytical performance of Abbott Real Time High Risk HPV test, J Clin Virol 45 (2009), S13-S17.
13. J. Monsonego, G. Pollini, M.J. Evrard et al., Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests, Sex Transm Dis 35 (2008), 521-527. (Pubitemid 351670554)
14. A.B. Moscicki, M. Schiffman, S. Kjaer and L.L. Villa, Chapter 5: Updatingthenatural history ofHPVandanogenital cancer, Vaccine 24(Suppl 3) (2006), S3/42-S3/51.
15. P. Halfon, G. Penaranda, M. Bourliere, H. Khiri, M.F. Massey-eff and D. Ouzan, Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation usingthe international unitstandard: implications for clinical management of patients with chronic hepatitis C virus infection, JMed Virol 78 (2006), 208-215. (Pubitemid 43132565)
16. P.E. Castle, J. Dockter, C Giachetti et al., A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical preCancer and cancer, Clin Cancer Res 13 (2007), 2599-2605. (Pubitemid 46788025)
17. V. Dalstein, S. Merlin, C Bali, M. Saunier, R. Dachez and C Ronsin, Analytical evaluation of the Papillo Check test, a new commercial DNA chip for detection and genotyping of human papillomavirus, J Virol Methods 156 (2009), 77-83.
18. N. Wentzensen, C Bergeron, F. Cas, S. Vinokurova and M. von Knebel Doeberitz, Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical in-traepithelial neoplasia, Cancer 111 (2007), 58-66. (Pubitemid 46281086)
19. A. Pista, A. Oliveira, A. Barateiro, H. Costa, N. Verdasca and M.T. Paixao, Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal, J Med Virol 79 (2007), 1889-1897. (Pubitemid 350006315)
20. A.K. Lie and G. Kristensen, Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma, Expert Rev Mol Diagn 8 (2008), 405-415. (Pubitemid 351962087)
21. J.S Smith, L. Lindsay, B. Hoots et al., Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update, Int J Cancer 121 (2007), 621-632. (Pubitemid 46986496)